FDA Clears Abbott OCT Imaging Enhanced With Artificial Intelligence dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.
Search jobs 04-Aug-2021 Abbott Receives FDA Clearance For Its Imaging Technology Using Artificial Intelligence For Vessels in the Heart - Ultreon™ 1.0 Software, the first-of-its-kind imaging software, merges optical coherence tomography with the power of automation using Artificial Intelligence
- The new intuitive interface provides step-by-step guidance to enhance ease of use
- When combined with Abbott s Dragonfly OpStar™ imaging catheter and PressureWire X™, the platform provides physicians with a comprehensive set of tools to provide better patient care
Abbott (NYSE: ABT) today announced it has received U.S. Food and Drug Administration (FDA) clearance for its latest optical coherence tomography (OCT) imaging platform powered by the company s new Ultreon Software. This innovative imaging software combines OCT with artificial intelligence (AI) to provide physicians an enhanced, comprehensive view of coronary bl
Abbott Receives FDA Clearance for its Imaging Technology Using Artificial Intelligence for Vessels in the Heart investingnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investingnews.com Daily Mail and Mail on Sunday newspapers.
Abbott’s new imaging platform powered by Ultreon 1.0 Software launches in Europe
Apr 30 2021
Abbott today announced that its new imaging platform powered by Ultreon 1.0 Software, is now CE Marked in Europe. This first-of-its-kind imaging software merges optical coherence tomography (OCT) – an imaging tool that provides physicians a comprehensive view inside an artery or blood vessel – with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.
Image Credit: Abbott
Unlike traditional imaging methods such as conventional angiography, Abbott’s OCT technology uses near-infrared light to provide high-definition, precise imaging from within a blood vessel. OCT imaging also helps improve physicians’ assessment of blockages in those vessels and optimize